Skip to main content
OKLO
NYSE Energy & Transportation

Oklo Q2 Loss Widens to $48.5M; $1.85B Raised via ATM, Groves Reactor Hits Criticality

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Utility Stocks · Utility
Sentiment info
Neutral
Importance info
8
Price
$42.99
Mkt Cap
$7.341B
52W Low
$36.61
52W High
$193.84
52W Position info
17% above low
Off High info
78% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

OKLO sits 17% above its 52-week low of $36.61.

Summary

Oklo reported a wider Q2 net loss of $48.5M on higher R&D spending, raised $1.85B via ATM in H1 2026, and announced its Groves test reactor achieved first criticality — a major technical milestone.


Key Events · Earnings and Guidance · OKLO

  • Q2 Net Loss Widens to $48.5M

    Net loss increased to $48.5M from $24.7M in Q2 2025, driven by a $28.0M increase in R&D and a $17.7M increase in G&A as the company scales its workforce and development activities.

  • $1.85B Raised via ATM in H1 2026

    Oklo raised $1.85 billion through its at-the-market programs in the first half of 2026, including $670 million in Q2, ending the quarter with $3.0 billion in cash and marketable securities.

  • Groves Reactor Achieves First Criticality

    On August 5, 2026, the Groves Isotope Test Reactor achieved first criticality, marking the first reactor under the DOE's RPP to reach this milestone on private land, validating Oklo's design and operational capabilities.

  • Two Acquisitions Closed in June

    Oklo acquired ARMEC and Creative Engineers for total consideration of $33.4M, adding precision manufacturing and chemical process engineering expertise to support its reactor and fuel projects.


Analysis · OKLO · Energy & Transportation

Oklo's Q2 results show a net loss of $48.5 million, up from $24.7 million a year ago, as R&D and G&A spending more than doubled to support its reactor and fuel programs. The company raised $1.85 billion through its ATM programs in the first half of 2026, including $670 million in Q2, ending the quarter with $3.0 billion in cash and marketable securities. Two acquisitions closed in June add precision manufacturing and chemical process engineering capabilities. The Groves Isotope Test Reactor achieved first criticality on August 5, 2026, a major technical milestone that validates the company's reactor design and operational readiness. The cash position provides a multi-year runway, but the accelerating cash burn and ongoing dilution from the ATM program are key investor concerns.

At the time of this filing, OKLO was trading at $42.99 on NYSE in the Energy & Transportation sector, with a market capitalization of approximately $7.3B. The 52-week trading range was $36.61 to $193.84. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

OKLO - Latest Insights

OKLO
Aug 06, 2026, 10:12 AM EDT
Source: Benzinga
Importance Score:
8
OKLO
Jul 23, 2026, 5:02 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
OKLO
Jul 01, 2026, 8:52 AM EDT
Source: Reuters
Importance Score:
9
OKLO
Jun 30, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
OKLO
Jun 16, 2026, 6:41 AM EDT
Source: Reuters
Importance Score:
8